Shire PLC Company Profile (LON:SHP)

About Shire PLC (LON:SHP)

Shire PLC logoShire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company's segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases. Its Hematology products include ADVATE (Antihemophilic Factor (Recombinant)), ADYNOVATE/ADYNOVI (Antihemophilic Factor (Recombinant), PEGylated)), RIXUBIS (Coagulation Factor IX (Recombinant)), VONVENDI (von Willebrand factor (Recombinant)) and FEIBA (Anti-Inhibitor Coagulant Complex). Its Genetic Diseases products include CINRYZE (C1 esterase inhibitor (human)), FIRAZYR (icatibant), ELAPRASE (idursulfase), REPLAGAL (agalsidase alfa) and VPRIV (velaglucerase alfa).

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Pharmaceuticals
  • Sub-Industry: N/A
  • Symbol: LON:SHP
  • CUSIP: N/A
  • Web:
  • Market Cap: £33.71 billion
  • Outstanding Shares: 906,400,000
Average Prices:
  • 50 Day Moving Avg: GBX 3,872.21
  • 200 Day Moving Avg: GBX 4,244.95
  • 52 Week Range: GBX 3,603.50 - GBX 5,210
  • Trailing P/E Ratio: 50.89
  • P/E Growth: 1.11
Sales & Book Value:
  • Annual Revenue: £14.58 billion
  • Price / Sales: 2.31
  • Book Value: GBX 34.49 per share
  • Price / Book: 1.08
  • Dividend Yield: 0.5%
  • EBITDA: £5.76 billion
  • Net Margins: 6.33%
  • Return on Equity: 3.18%
  • Return on Assets: 1.43%
  • Average Volume: 2.66 million shs.

Frequently Asked Questions for Shire PLC (LON:SHP)

What is Shire PLC's stock symbol?

Shire PLC trades on the London Stock Exchange (LON) under the ticker symbol "SHP."

How often does Shire PLC pay dividends? What is the dividend yield for Shire PLC?

Shire PLC announced a dividend on Thursday, August 3rd. Shareholders of record on Thursday, September 7th will be paid a dividend of GBX 3.85 per share on Friday, October 20th. This represents a yield of 0.1%. The ex-dividend date of this dividend is Thursday, September 7th. The official announcement can be seen at this link. View Shire PLC's Dividend History.

When will Shire PLC make its next earnings announcement?

Shire PLC is scheduled to release their next quarterly earnings announcement on Friday, October, 27th 2017. View Earnings Estimates for Shire PLC.

Where is Shire PLC's stock going? Where will Shire PLC's stock price be in 2017?

18 brokerages have issued 1-year price targets for Shire PLC's shares. Their predictions range from GBX 4,400 to GBX 7,500. On average, they expect Shire PLC's share price to reach GBX 5,878.47 in the next twelve months. View Analyst Ratings for Shire PLC.

Who are some of Shire PLC's key competitors?

Who are Shire PLC's key executives?

Shire PLC's management team includes the folowing people:

  • Flemming Ornskov M.D., Chief Executive Officer, Executive Director
  • Jeffrey Poulton, Chief Financial Officer, Executive Director
  • Joanne Cordeiro, Chief Human Resource Officer
  • William Mordan, General Counsel, Company Secretary
  • Perry Sternberg, Head - U.S. Commercial
  • Kim Stratton, Head - International Commercial
  • Philip J. Vickers, Head - Research and Development
  • Matthew Walker, Head - Technical Operations
  • Susan Saltzbart Kilsby, Independent Non-Executive Chairman of the Board
  • Olivier Bohuon, Non-Executive Director

How do I buy Shire PLC stock?

Shares of Shire PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Shire PLC's stock price today?

One share of Shire PLC stock can currently be purchased for approximately GBX 3,719.50.

MarketBeat Community Rating for Shire PLC (LON SHP)
Community Ranking:  4.1 out of 5 (star star star star)
Outperform Votes:  1,094 (Vote Outperform)
Underperform Votes:  231 (Vote Underperform)
Total Votes:  1,325
MarketBeat's community ratings are surveys of what our community members think about Shire PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Shire PLC (LON:SHP) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 14 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.89)
Consensus Price Target: GBX 5,878.47
Consensus Price Target History for Shire PLC (LON:SHP)
Price Target History for Shire PLC (LON:SHP)
Analysts' Ratings History for Shire PLC (LON:SHP)
DateFirmActionRatingPrice TargetDetails
10/17/2017Goldman Sachs Group, Inc. (The)Reiterated RatingConviction-BuyView Rating Details
10/12/2017Morgan StanleyLower Price TargetOverweightGBX 5,800 -> GBX 5,700View Rating Details
10/5/2017Deutsche Bank AGReiterated RatingBuyGBX 5,700View Rating Details
10/3/2017Liberum CapitalReiterated RatingHoldGBX 4,400View Rating Details
9/20/2017Shore CapitalReiterated RatingBuyView Rating Details
9/13/2017J P Morgan Chase & CoLower Price TargetOverweightGBX 5,500 -> GBX 5,300View Rating Details
8/22/2017Credit Suisse GroupReiterated RatingOutperformGBX 5,350View Rating Details
8/22/2017Jefferies Group LLCReiterated RatingBuyView Rating Details
8/22/2017Citigroup Inc.Reiterated RatingBuyGBX 6,300View Rating Details
8/11/2017Barclays PLCDowngradeEqual weightView Rating Details
8/9/2017Berenberg BankReiterated RatingBuyGBX 6,000View Rating Details
8/4/2017Beaufort SecuritiesReiterated RatingLong Term BuyGBX 6,200 -> GBX 4,900View Rating Details
7/12/2017Societe GeneraleReiterated RatingBuyGBX 7,500View Rating Details
7/7/2017Royal Bank Of CanadaReiterated RatingOutperformView Rating Details
7/6/2017HSBC Holdings plcUpgradeHoldGBX 4,450View Rating Details
4/3/2017BNP ParibasReiterated RatingOutperformGBX 5,900View Rating Details
1/9/2017Bryan, Garnier & CoReiterated RatingBuyGBX 6,800View Rating Details
11/7/2016AlphaValueReiterated RatingBuyGBX 6,714View Rating Details
11/3/2016Bank of America CorporationReiterated RatingBuyGBX 6,970View Rating Details
3/15/2016Sanford C. BernsteinReiterated RatingOutperformGBX 5,000View Rating Details
1/12/2016S&P Equity ResearchReiterated RatingBuyView Rating Details
12/3/2015InvestecDowngradeSellView Rating Details
11/3/2015Kepler Capital MarketsLower Price TargetBuyGBX 6,000 -> GBX 5,900View Rating Details
(Data available from 10/18/2015 forward)


Earnings History for Shire PLC (LON:SHP)
No earnings announcements for this company have been tracked by


Earnings Estimates for Shire PLC (LON:SHP)
Current Year EPS Consensus Estimate: $5.00 EPS


Dividend History by Quarter for Shire PLC (LON SHP)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/3/2017GBX 3.850.1%9/7/20179/7/201710/20/2017
2/16/2017GBX 20.640.43%3/9/20173/9/20174/25/2017
8/2/2016GBX 3.510.07%9/8/20169/8/201610/7/2016
2/11/2016GBX 15.320.44%3/10/20163/10/20164/12/2016
7/23/2015GBX 2.690.05%9/3/20159/3/201510/2/2015
7/18/2014GBX 2.240.04%9/3/20149/3/201410/3/2014
2/13/2014GBX 10.210.31%3/5/20143/5/20144/8/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Shire PLC (LON:SHP)
Insider Trades by Quarter for Shire PLC (LON:SHP)
Insider Trades by Quarter for Shire PLC (LON:SHP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/29/2017Anne MintoInsiderBuy190GBX 3,785£7,191.50
8/22/2017Flemming OrnskovInsiderBuy8,400GBX 3,665£307,860
6/30/2017Dominic BlakemoreInsiderBuy152GBX 4,255£6,467.60
3/31/2017William BurnsInsiderBuy136GBX 4,742£6,449.12
12/16/2016Olivier BohuonInsiderBuy141GBX 4,528£6,384.48
9/30/2016Dominic BlakemoreInsiderBuy133GBX 5,010£6,663.30
6/30/2016Bohuon,OlivierInsiderBuy134GBX 4,463£5,980.42
3/31/2016Bohuon,OlivierInsiderBuy133GBX 3,908£5,197.64
2/15/2016Bohuon,OlivierInsiderBuy1,000GBX 3,552£35,520
2/12/2016Burns,WilliamInsiderBuy1,250GBX 3,563£44,537.50
12/18/2015Burns,WilliamInsiderBuy156GBX 4,457£6,952.92
9/30/2015Blakemore ,DominicInsiderBuy129GBX 4,498£5,802.42
6/30/2015Kappler,David JInsiderBuy126GBX 51.05GBX 6,432.30
3/31/2015Susan KilsbyInsiderBuy375GBX 5,327£19,976.25
12/19/2014Steven GillisInsiderBuy228GBX 4,654£10,611.12
10/30/2014Steven GillisInsiderBuy381GBX 4,098£15,613.38
(Data available from 1/1/2013 forward)


Headline Trends for Shire PLC (LON:SHP)
Latest Headlines for Shire PLC (LON:SHP)
DateHeadline logoMorgan Stanley Trims Shire PLC (SHP) Target Price to GBX 5,700 - October 15 at 12:16 PM logoShire plc : New Formulation of ONCASPAR® (pegaspargase) Receives Positive CHMP Opinion in Europe for Patients with Acute Lymphoblastic Leukemia (ALL) - October 13 at 2:14 AM logoShire plc : Notice of Results - GlobeNewswire (press release) - October 12 at 4:06 PM logoShire Plc breached its 50 day moving average in a Bearish Manner : SHP-GB : October 9, 2017 - October 10 at 6:50 AM logoShire PLC (SHP) Receives Average Rating of "Buy" from Analysts - October 8 at 10:44 AM logoShire PLC (SHP) Receives "Buy" Rating from Deutsche Bank AG - October 8 at 10:04 AM logoInsider Buying: Shire PLC (SHP) Insider Acquires 190 Shares of Stock - October 3 at 10:18 AM logoShould You Sell Shire plc (LSE:SHP) At £37.78? - September 30 at 9:46 AM logoWhy Allergan is Jumping - September 26 at 9:33 AM logoShore Capital Reiterates "Buy" Rating for Shire PLC (SHP) - September 24 at 6:30 AM logoIs Shire plc (SHPG) a Suitable Value Stock? - September 23 at 6:34 AM logoJ P Morgan Chase & Co Cuts Shire PLC (SHP) Price Target to GBX 5,300 - September 17 at 6:28 PM logoShire PLC (SHP) Receives Average Recommendation of "Buy" from Analysts - September 13 at 10:36 AM logoShire Plc – Value Analysis (LONDON:SHP) : September 13, 2017 - September 13 at 9:08 AM logoShire's Investigational Subcutaneous C1 esterase inhibitor (C1 INH [Human]) Liquid for Injection (S - September 12 at 9:46 AM logoTOP NEWS: Shire Gets Fast-Track Designation For SHP607 In Lung Disease - September 12 at 9:46 AM logoShire's SHP607 Fast Track'd in U.S. for preventing chronic lung disease in extremely premature infants - September 12 at 9:46 AM logoShire Plc Announces Fast Track Designation For SHP607 - Quick Facts - September 12 at 9:46 AM logoShire Plc breached its 50 day moving average in a Bullish Manner : SHP-GB : September 11, 2017 - September 11 at 6:49 AM logoShire PLC Plans Dividend of GBX 3.85 (SHP) - September 2 at 10:18 AM logoShire plc Director and Senior Management Changes - GlobeNewswire - GlobeNewswire (press release) - August 23 at 11:35 AM logoFlemming Ornskov Purchases 8,400 Shares of Shire PLC (SHP) Stock - August 22 at 1:14 PM logoShire's finance head Jeff Poulton to step down - August 22 at 6:40 AM logoShire PLC (SHP) Given Consensus Recommendation of "Buy" by Analysts - August 19 at 10:50 AM logoDenmark's ISS hit by headwind in Sweden and China, shares down - August 17 at 7:33 AM logoShire Announces Submission Of MAA For Lifitegrast - Quick Facts - August 16 at 7:29 AM logoShire PLC (LON:SHP) Price Target Lowered to GBX 5,250 at Jefferies Group LLC - August 7 at 6:34 AM logoEdited Transcript of SHP.L earnings conference call or presentation 3-Aug-17 1:00pm GMT - August 5 at 7:00 AM logoBHP Billiton plc and Shire plc could be the FTSE 100’s best bargains - July 30 at 6:10 AM logoShire PLC (SHP) Stock Rating Reaffirmed by J P Morgan Chase & Co - July 23 at 10:04 AM logo[$$] Shire boss says share price at odds with drugs pipeline - July 16 at 3:55 PM logoShire PLC (LON:SHP) Stock Rating Upgraded by HSBC Holdings plc - July 9 at 2:16 PM logoRoyal Bank Of Canada Reiterates Outperform Rating for Shire PLC (SHP) - July 8 at 8:32 AM logoShire Completes NDA Filing for Hemophilia Drug with FDA - July 7 at 11:14 AM logoBritish ministers call for post-Brexit drug deal with EU - July 4 at 7:20 AM logoShire PLC (LON:SHP) Price Target Cut to GBX 6,400 by Analysts at Goldman Sachs Group, Inc. (The) - July 3 at 10:46 PM logoShire PLC's (LON:SHP) "Buy" Rating Reiterated at Deutsche Bank AG - July 3 at 5:10 PM logoBarclays PLC Reiterates Overweight Rating for Shire PLC (LON:SHP) - July 3 at 1:33 PM logoInsider Buying: Shire PLC (LON:SHP) Insider Acquires 152 Shares of Stock - July 3 at 1:20 PM logoShire PLC's (SHP) Hold Rating Reiterated at Liberum Capital - July 2 at 10:34 PM logoShire Says EMA Validates Veyvondi MAA For Treatment Of Von Willebrand Disease - June 22 at 1:31 PM logoShire : FDA Approves Mydayis, New Once-Daily Option For ADHD Symptom Control - June 21 at 5:20 AM logoBrexit Winners: Why JPMorgan Is Buying UK Stocks - June 3 at 12:20 AM logoShire's swelling disorder drug moves closer to U.S. approval - Nasdaq - May 18 at 1:08 PM logoShire Stock Lifted By First-Quarter Earnings Beat - - May 2 at 5:38 PM logoUK Stocks-Factors to watch on May 2 - May 2 at 9:08 AM logoShire profit drops 11%, revenue more than doubles - May 2 at 9:08 AM logoShire Partner Receives Approval For INTUNIV In Japan To Treat ADHD In Children - March 30 at 8:06 PM logoREFILE-Alexion Pharma names former Baxalta head Ludwig Hantson CEO - March 27 at 9:12 AM logoShire Gets US FDA Fast Track Designation For SHP655 - March 22 at 8:25 AM


Social activity is not available for this stock.


Shire PLC (SHP) Chart for Wednesday, October, 18, 2017

This page was last updated on 10/18/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.